In response to the declaration of global pandemic of Coronavirus infectious disease 2019 (COVID-19) caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we provide comprehensive content on Coronavirus molecular structures and its interactions:

Search

SARS-CoV-2 Envelope Protein Transmembrane Domain: Pentameric Structure Determined by Solid-State NMR
Authors
Mandala, V.S., Hong, M., McKay, M.J., Shcherbakov, A.S., Dregni, A.J.
Assembly
Envelope small membrane protein
Entity
1. Envelope small membrane protein (polymer, Thiol state: not present), 31 monomers, 3361.105 × 5 Da Detail

ETGTLIVNSV LLFLAFVVFL LVTLAILTAL R


Total weight
16805.525 Da
Max. entity weight
3361.105 Da
Source organism
Severe acute respiratory syndrome coronavirus 2
Exptl. method
solid-state NMR
Refine. method
simulated annealing
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 93.5 %, Completeness: 82.1 %, Completeness (bb): 91.1 % Detail

Polymer type: polypeptide(L)

Total13C15N
All82.1 % (156 of 190)81.5 % (128 of 157)84.8 % (28 of 33)
Backbone91.1 % (112 of 123)92.4 % (85 of 92)87.1 % (27 of 31)
Sidechain74.2 % (72 of 97)74.7 % (71 of 95)50.0 % (1 of 2)
Aromatic 0.0 % (0 of 15) 0.0 % (0 of 15)
Methyl87.2 % (34 of 39)87.2 % (34 of 39)

1. entity 1

ETGTLIVNSV LLFLAFVVFL LVTLAILTAL R

Sample #1

Solvent system aqueous buffer, Pressure 1 atm, Temperature 293 K, pH 7.5 (±0.2), Details 0.1 mg/uL [U-13C; U-15N] SARS-CoV-2 Envelope Protein Transmembrane Domain, 0.23 mg/uL POPC, 0.1 mg/uL POPE, 0.08 mg/uL bovine PI, 0.04 mg/uL POPS, 0.04 mg/uL Cholesterol, aqueous buffer.


#NameIsotope labelingTypeConcentration
1SARS-CoV-2 Envelope Protein Transmembrane Domain[U-13C; U-15N]0.1 mg/uL
2POPCnatural abundance0.23 mg/uL
3POPEnatural abundance0.1 mg/uL
4bovine PInatural abundance0.08 mg/uL
5POPSnatural abundance0.04 mg/uL
6Cholesterolnatural abundance0.04 mg/uL
Sample #2

Solvent system aqueous buffer, Pressure 1 atm, Temperature 293 K, pH 7.5 (±0.2), Details 0.1 mg/uL [U-13C; U-15N] SARS-CoV-2 Envelope Protein Transmembrane Domain, 0.1 mg/uL [4-19F-Phe] fluoro SARS-CoV-2 Envelope Protein Transmembrane Domain, 0.23 mg/uL POPC, 0.1 mg/uL POPE, 0.08 mg/uL bovine PI, 0.04 mg/uL POPS, 0.04 mg/uL Cholesterol, aqueous buffer.


#NameIsotope labelingTypeConcentration
7SARS-CoV-2 Envelope Protein Transmembrane Domain[U-13C; U-15N]0.1 mg/uL
8POPCnatural abundance0.23 mg/uL
9POPEnatural abundance0.1 mg/uL
10bovine PInatural abundance0.08 mg/uL
11POPSnatural abundance0.04 mg/uL
12Cholesterolnatural abundance0.04 mg/uL
13fluoro SARS-CoV-2 Envelope Protein Transmembrane Domain[4-19F-Phe]0.1 mg/uL
Sample #3

Solvent system aqueous buffer, Pressure 1 atm, Temperature 293 K, pH 7.5 (±0.2), Details 0.1 mg/uL [U-15N] 15N SARS-CoV-2 Envelope Protein Transmembrane Domain, 0.1 mg/uL [U-13C] 13C SARS-CoV-2 Envelope Protein Transmembrane Domain, 0.23 mg/uL POPC, 0.1 mg/uL POPE, 0.08 mg/uL bovine PI, 0.04 mg/uL POPS, 0.04 mg/uL Cholesterol, aqueous buffer.


#NameIsotope labelingTypeConcentration
14POPCnatural abundance0.23 mg/uL
15POPEnatural abundance0.1 mg/uL
16bovine PInatural abundance0.08 mg/uL
17POPSnatural abundance0.04 mg/uL
18Cholesterolnatural abundance0.04 mg/uL
1915N SARS-CoV-2 Envelope Protein Transmembrane Domain[U-15N]0.1 mg/uL
2013C SARS-CoV-2 Envelope Protein Transmembrane Domain[U-13C]0.1 mg/uL

Protein Blocks Logo
Calculated from 10 models in PDB: 7K3G, Strand ID: A, B, C, D, E Detail


Release date
2020-09-21
Citation
Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers
Mandala, V.S., McKay, M.J., Shcherbakov, A.A., Dregni, A.J., Kolocouris, A., Hong, M.
Res. Sq. (2020), 27, 1202-1208, PubMed 32995764 , DOI 10.21203/rs.3.rs-77124/v1 ,
Related entities 1. Envelope small membrane protein, : 1 : 4 : 1 : 7 entities Detail
Experiments performed 6 experiments Detail
Chemical shift validation 3 contents Detail
Keywords Pentameric Ion Channel, Transmembrane Domain, VIRAL PROTEIN, Viroporin